Hackensack University Medical Center — Hackensack, New Jersey

Public research footprint of Hackensack University Medical Center, compiled from the ClinicalTrials.gov public registry.

1,372

Registered studies

417

Active

195

Recruiting now

698

Completed

205

Stopped or withdrawn

Most-studied conditions

Anatomic Stage II Breast Cancer AJCC v8 · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Ovarian Cancer Metastatic Recurrent · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT06632977 — Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (Recruiting)
NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hackensack University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.